The ETVSS has developed by Kulkarni et al in order to predict the clinical response following ETV based on age, previous shunt and cause of hydrocephalus in a pediatric population and has been validat
Background: The substantial heterogeneity of clinical symptoms and lack of reliable progression markers in Parkinson's disease (PD) present a major challenge in predicting accurate progression and pro
Numbers are column percentages, with absolute numbers in parentheses. The percentages sometimes do not add up to 100% because development studies commonly reported more than one performance measure or
BackgroundFor this study, we explored the prognostic profiles of biliary neuroendocrine neoplasms (NENs) patients and identified factors related to prognosis. Further, we developed and validated an ef
